Prevalence of pulmonary embolism and deep venous thrombosis during the COVID-19 pandemic in an intensive care unit cohort: a service evaluation
- 11 August 2022
- journal article
- letter
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 129 (5) , e124-e126
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort studyBMJ, 2022
- Multi-organ point-of-care ultrasound for detection of pulmonary embolism in critically ill COVID-19 patients – A diagnostic accuracy studyJournal of Critical Care, 2022
- Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19JAMA Internal Medicine, 2021
- Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care UnitJAMA, 2021
- Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019Chest, 2021
- Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-AnalysisRadiology, 2021
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine, 2020
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020